Global Irritable Bowel Syndrome Market Outlook

Irritable bowel syndrome is one of the foremost common disorders that affect the massive intestine. It causes cramping, abdominal pain, bloating, diarrhea, gas, and constipation. The disease is additionally referred to as irritable bowel syndrome, irritable bowel syndrome, spastic colitis, and irritable colon. The global irritable bowel syndrome treatment market size was valued at USD 1.5 billion in 2019 and is anticipated to exhibit a CAGR of 10.1% over the forecast period. The rising prevalence of target disease, including increasing uptake of medicine for an equivalent, is driving the market. Rising commercialization of existing products in several regions is predicted to accelerate growth over the forecast period

Top Driver: Rising commercialization of existing products in several regions is predicted to accelerate growth over the forecast period
A robust pipeline with symptom-specific indications and subsequent launches within the forecast period is predicted to spice up the market.
According to International Foundation for Functional Gastrointestinal Disorders, 2019, the worldwide prevalence of irritable bowel syndrome is around 10-15%. Furthermore, there are between 2.4 and 3.5 million annual physician visits for IBS within the U.S. consistent with an equivalent source. Consistent with the Anxiety and Depression Association of America, approximately one in five adults within the U.S. are suffering from irritable bowel syndrome. Irritable bowel syndrome shows a good range of symptoms, so, the treatment is set on the predominance of the symptoms like, in pain predominant patients, antispasmodic agents or tricyclic antidepressants are used. The prevalence of irritable bowel syndrome is more predominant in females than in males. Consistent with the International Foundation for Functional Gastrointestinal Disorders, 2 in 3 IBS sufferers are female. A number of the U.S. Food & Drug Administration-approved drugs for relieving the symptoms related to IBS are Lotronex (Alosetron), Amitiza (Lubiprostone), Linzess (Linaclotide), and Xifaxan (Rifaximin.



Xifaxan-type to Make Crucial Contribution to Growth of Irritable bowel syndrome
As per the type, the market is segmented on the idea of type into Diarrhea-predominant (IBS-D) and Constipation-predominant (IBS-C). IBS-C was the most important revenue-generating segment in 2018 due to the factors like increasing prevalence and rising uptake of medicine like Linzess/Constella and Amitiza. Furthermore, the segment is estimated to exhibit the fastest rate of growth within the irritable bowel syndrome (IBS) treatment market over the forecast period thanks to the expected launch of promising products like SYN-010 and Tenapanor, which are currently under clinical trials. Allergan, Ironwood, Astellas, and AstraZeneca are a number of the main players operating during this segment.

As per the product, leading products developed for the treatment of symptoms of irritable bowel syndrome includeXifaxan, Linzess/Constella, Viberzi, and Amitiza. Linzess/Constella (Linaclotide) was estimated to be the most important revenue-generating product segment in 2018 due to factors like rising adoption of the merchandise in major regions like the U.S., U.K., Germany, Spain, Italy, and Japan. Furthermore, Linzess witnessed a big rate of growth in Japan in 2018. The Linzess/Constella segment is estimated to register the fastest growth over the course of the forecast period. Linaclotide is marketed by Ironwood and Allergan in the U.S. as Linzess and is marketed by Allergan in Europe under the name Constella. In Japan and China, Astellas and AstraZeneca have the exclusive rights to develop and market linaclotide as Linzess respectively.

North America is expected to witness the fastest growth in the Irritable bowel syndrome market
As per the region, the worldwide irritable bowel syndrome treatment market is segmented into the Asia-Pacific, North America, Europe, South America, and Middle East & Africa. North America is estimated to steer the worldwide market in 2019, due to growing awareness regarding the condition and presence of major players within the region, like Abbott, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Ardelyx Inc., and Ironwood Pharmaceuticals, Inc. The European market is predicted to garner significant market share due to the rising prevalence of IBS and the growing commercialization of the IBS treatment products. Consistent with a report published by Allergan Inc., the prevalence of IBS in Europe in 2016 was 7.1%. The irritable bowel syndrome treatment market is that the Asia-Pacific region is anticipated to grow at the fastest CAGR due to the presence of a giant patient population affected by IBS and the increasing geriatric population within the region. The market in South America is predicted to garner significant market share due to the increasing incidence rate of IBS. The center East & Africa irritable bowel syndrome treatment market is predicted to demonstrate the least growth due to the low awareness regarding the disease and its treatment, especially within the African region.

Players to Focus on Irritable bowel syndrome market
Key market players covered within the report include Abbott (US), Synergy Pharmaceuticals, Inc. (US), Sucampo Pharmaceuticals, Inc. (the US), Bausch Health (Canada), Ardelyx, Inc. (US), Astellas Pharma Inc. (Japan), Novartis AG (Switzerland), GlaxoSmithKline Plc (UK), and Ironwood Pharmaceuticals, Inc. (US), among others. These companies are involved in product approvals, mergers, partnerships, and other such strategic activities to grow within the market.

Synergy Pharmaceuticals Inc: in January 2018, Synergy Pharmaceuticals Inc. received US Food and medicines Administration (FDA) approval for Trulance, a drug for the treatment of constipation-predominant IBS-C in adults. With this product approval, the corporate expanded its product portfolio.
Allergan plc: in May 2018, Allergan plc together with Ironwood Pharmaceuticals Inc. launched the AboutYourGut.com website so as to make awareness regarding the disease. This awareness initiative helped the businesses to make a competitive edge over other market players.

Scope of the Report
By Type
• IBS-C
• Linzess/Constella
• Amitiza
• Xifaxan
• Viberzi
• Chemicals
By End user
• Hospitals Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies
By Region
• North America
• Europe
• Asia Pacific
• Rest Of World


Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.

2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.

3. It renders a definite analysis for changing competitive dynamics.

4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation

Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted

Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary

Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis

Chapter 5 Global Irritable bowel syndrome Market Forces
5.1 What’s Driving the Market
5.2 Porter’s Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition

Chapter 6 Global Irritable bowel syndrome Market -Industry Snapshots
6.1 Overview
6.1.1 Global Irritable bowel syndrome Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis

Chapter 7 Global Irritable bowel syndrome Market Analysis, by Type
7.1 Overview
7.2 Key Findings for Irritable bowel syndrome Market- By Type
7.2.1 Irritable bowel syndrome Market- IBS-C
Irritable bowel syndrome market by Type 1, 2019 - 2028 (USD Million)
7.2.2 Irritable bowel syndrome Market- Xifaxan
Irritable bowel syndrome market by Type 2, 2019 - 2028 (USD Million)

Chapter 8 Global Irritable bowel syndrome Market Analysis, by End user
8.1 Overview
8.2 Key Findings for Irritable bowel syndrome Market- By End user Irritable bowel syndrome Market- Household
Irritable bowel syndrome market by End user 1, 2019 - 2028 (USD Million)
8.2.1 Irritable bowel syndrome Market- Hospitals Pharmacies
Irritable bowel syndrome market by End user
8.2.2 Irritable bowel syndrome Market- Drug Stores & Retail Pharmacies
8.2.3 Irritable bowel syndrome Market- Online Pharmacies

Chapter 9 Irritable bowel syndrome Market Analysis by Region
9.1 Key Findings for Irritable bowel syndrome Market- By region
9.2 Overview
9.2.1 Global Irritable bowel syndrome Market Analysis, By Type, 2019 - 2028
9.2.2 Global Irritable bowel syndrome Market Analysis, By Product Type, 2019 - 2028
9.3 Irritable bowel syndrome Market – North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.3.5 North America Market, By Type
9.3.6 North America Market, By Product Type
9.4 Irritable bowel syndrome Market – Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.4.7 Europe Market, By Type
9.4.8 Europe Market, By Product Type
9.5 Irritable bowel syndrome Market – Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.5.6 Asia Pacific Market, By Type
9.5.7 Asia Pacific Market, By Product Type
9.6 Irritable bowel syndrome Market – Rest Of World
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 South America
9.6.4 Rest Of World
9.6.5 South America, Middle East and Africa Market, By Type
9.6.6 South America, Middle East and Africa Market, By Product Type

Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Vendors, 2019
10.1.2 Key Strategies Adopted by the Leading Players
10.1.3 Recent Developments

Chapter 11 Company Profiles- Snapshot
11.1.1 Allergan plc
11.1.2 Business Fundamentals
11.1.3 Financial Snapshots
11.1.4 Product Portfolio
11.1.5 Recent Developments
11.2 Abbott (US),
11.3 Synergy Pharmaceuticals, Inc. (US),
11.4 Sucampo Pharmaceuticals, Inc. (US),
11.5 Bausch Health (Canada),
11.6 Ardelyx, Inc. (US),
11.7 Astellas Pharma Inc. (Japan),
11.8 Novartis AG (Switzerland),
11.9 GlaxoSmithKline Plc (UK),
11.10 Ironwood Pharmaceuticals, Inc. (US),
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies

Chapter 12 Appendix

List Of Tables

TABLE 1 2, 2019 - 2028 (USD Million)
TABLE 2 Irritable bowel syndrome market by End user 3, 2019 - 2028 (USD Million)
TABLE 3 Irritable bowel syndrome market by End user 4, 2019 - 2028 (USD Million)
TABLE 4 Global Irritable bowel syndrome Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 5 Global Irritable bowel syndrome Market Value, By Product Type, 2019 - 2028 (US$ Bn)
TABLE 6 Irritable bowel syndrome Market Analysis by North America (USD Million), 2019 - 2028
TABLE 7 U.S. Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 8 U.S. Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 9 U.S. Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 10 Canada Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 11 Canada Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 12 Canada Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 13 Mexico Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 14 Mexico Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 15 Mexico Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 16 Irritable bowel syndrome Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 17 Germany Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 18 Germany Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 19 Germany Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 20 United Kingdom Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 21 United Kingdom Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 22 United Kingdom Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 23 France Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 24 France Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 25 France Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 26 Italy Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 27 Italy Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 28 Italy Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 29 Rest Of Europe Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 30 Rest Of Europe Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 31 Rest Of Europe Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 32 Irritable bowel syndrome Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 33 China Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 34 China Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 35 China Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 36 Japan Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 37 Japan Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 38 Japan Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 39 India Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 40 India Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 41 India Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 42 Rest of APAC Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 43 Rest of APAC Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 44 Rest of APAC Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 45 Irritable bowel syndrome Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 46 Middle East & Africa (MEA) Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 47 Middle East & Africa (MEA) Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 48 Middle East & Africa (MEA) Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 49 South America Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 50 South America Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 51 South America Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 52 Rest Of World Irritable bowel syndrome Market, 2019 - 2028 (USD Million)
TABLE 53 Rest Of World Irritable bowel syndrome Market, By Type, 2019 - 2028 (USD Million)
TABLE 54 Rest Of World Irritable bowel syndrome Market, By Product Type, 2019 - 2028 (USD Million)

List Of Figures

FIG. 1 Global Irritable bowel syndrome : Market Segmentation
FIG. 2 Global Irritable bowel syndrome Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porter’s Five Forces Analysis
FIG. 6 Global Irritable bowel syndrome Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Irritable bowel syndrome Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Irritable bowel syndrome Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 10 Global Irritable bowel syndrome Market Value, 2019 - 2028, (US$ Bn)
FIG. 11 North America Irritable bowel syndrome Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 Irritable bowel syndrome Market Segment 1 – North America
FIG. 13 Irritable bowel syndrome Market Segment 2 – North America
FIG. 14 Irritable bowel syndrome U.S. outlook, 2019 & 2026
FIG. 15 Irritable bowel syndrome Canada outlook, 2019 & 2026
FIG. 16 Irritable bowel syndrome Mexico outlook, 2019 & 2026
FIG. 17 Europe Irritable bowel syndrome Market Value, 2019 - 2028, (US$ Bn)
FIG. 18 Irritable bowel syndrome Market Segment 1 – Europe
FIG. 19 Irritable bowel syndrome Market Segment 2 – Europe
FIG. 20 Irritable bowel syndrome Germany outlook, 2019 & 2026
FIG. 21 Irritable bowel syndrome United Kingdom outlook, 2019 & 2026
FIG. 22 Irritable bowel syndrome France outlook, 2019 & 2026
FIG. 23 Irritable bowel syndrome Italy outlook, 2019 & 2026
FIG. 24 Irritable bowel syndrome Rest Of Europe outlook, 2019 & 2026
FIG. 25 Asia Pacific Irritable bowel syndrome Market Value, 2019 - 2028, (US$ Bn)
FIG. 26 Irritable bowel syndrome Market Segment 1 – Asia Pacific
FIG. 27 Irritable bowel syndrome Market Segment 2 – Asia Pacific
FIG. 28 Irritable bowel syndrome China outlook, 2019 & 2026
FIG. 29 Irritable bowel syndrome Japan outlook, 2019 & 2026
FIG. 30 Irritable bowel syndrome India outlook, 2019 & 2026
FIG. 31 Irritable bowel syndrome Rest of APAC outlook, 2019 & 2026
FIG. 32 Rest Of World Irritable bowel syndrome Market Value, 2019 - 2028, (US$ Bn)
FIG. 33 Irritable bowel syndrome Market Segment 1 – Rest Of World
FIG. 34 Irritable bowel syndrome Market Segment 2 – Rest Of World
FIG. 35 Irritable bowel syndrome Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 36 Irritable bowel syndrome South America outlook, 2019 & 2026
FIG. 37 Irritable bowel syndrome Rest Of World outlook, 2019 & 2026

Fill The Form For Sample Request

There is no Reviews available